Trellus Health PLC (GB:TRLS) has released an update.
Trellus Health PLC, a company specializing in the management of chronic conditions, is set to unveil its interim results for the period ending June 30, 2024, on September 26. The announcement will be complemented by a video update from CEO Dr. Marla Dubinsky and CFO Joy Bessenger, accessible through the company’s website and the Investor Meet Company platform. Trellus Health is known for its innovative Trellus Elevate program, which has demonstrated significant improvements in patient outcomes and reductions in healthcare costs through its resilience-based methodology.
For further insights into GB:TRLS stock, check out TipRanks’ Stock Analysis page.
